Sbc Medical Group Posts Weak Fiscal Q2
Sbc Medical Group (NASDAQ:SBC), a provider of cosmetic and medical services with a broad franchise and technology platform, released its earnings for the second quarter of fiscal 2025 on August 13, 2025. The company reported GAAP earnings per share of $0.02 and revenue of $43,358,847. Both figures missed analyst estimates, with GAAP EPS 85% below the consensus $0.135 projection and revenue down 3.8% from the expected $44.71 million. Year-over-year, GAAP revenue declined by 18% and net earnings dropped 87%, as the company underwent major structural changes and strategic divestitures. Overall, the quarter showed meaningful contraction in both topline and profitability metrics, offset partially by strong gains in customer and franchise volume. Despite these operational advances, margin compression and the lack of forward guidance remain important concerns for investors reviewing this release.
Source: Analyst estimates for the quarter provided by FactSet.
Sbc Medical Group operates as a franchise-based provider of cosmetic surgeries, medical treatments, and related healthcare support. It serves millions of customers across Japan and has started expanding into other regions. Its portfolio covers surgical and non-surgical procedures, as well as It solutions, procurement, and business management support for affiliated clinics.
Source Fool.com
